Cargando…

In Vitro–Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019

OBJECTIVES: Corticosteroid therapy has become standard of care therapy for hospitalized patients infected with the severe acute respiratory syndrome coronavirus-2 global pandemic-causing virus. Whereas systemic inflammation is a notably important feature in coronavirus disease 2019 pathogenesis, ada...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazer, Monty B., Davitt, Ethan, Turnbull, Isaiah R., Caldwell, Charles C., Brakenridge, Scott C., Remy, Kenneth E., Hotchkiss, Richard S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021361/ https://www.ncbi.nlm.nih.gov/pubmed/33834168 http://dx.doi.org/10.1097/CCE.0000000000000378

Ejemplares similares

Interleukin-7 Reverses Lymphopenia and Improves T-Cell Function in Coronavirus Disease 2019 Patient With Inborn Error of Toll-Like Receptor 3: A Case Report
por: Mazer, Monty B., et al.
Publicado: (2021)

COVID-19 disease and immune dysregulation
por: Davitt, Ethan, et al.
Publicado: (2022)

IL-7 Immunotherapy in a Nonimmunocompromised Patient With Intractable Fungal Wound Sepsis
por: Turnbull, Isaiah R, et al.
Publicado: (2021)

Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
por: Daix, Thomas, et al.
Publicado: (2023)

Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
por: Laterre, Pierre Francois, et al.
Publicado: (2020)

Combination Therapy With Tocilizumab and Dexamethasone Cost-Effectively Reduces Coronavirus Disease 2019 Mortality
por: Sinha, Pranay, et al.
Publicado: (2021)

Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19
por: Turnbull, Isaiah R., et al.
Publicado: (2021)

Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis
por: Loftus, Tyler J., et al.
Publicado: (2021)

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
por: Remy, Kenneth E., et al.
Publicado: (2020)

Dysregulation of the leukocyte signaling landscape during acute COVID-19
por: Turnbull, Isaiah R., et al.
Publicado: (2022)

Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
por: Aarskog, Nikolai Ravn, et al.
Publicado: (2021)

Dexamethasone: a corticosteroid drug for the treatment of coronavirus disease 2019
por: Riaz, Muhammad, et al.
Publicado: (2022)

Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy
por: Schwab, Kristin, et al.
Publicado: (2020)

Dexamethasone to the rescue
por: Moon, Chang
Publicado: (2020)

Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19
por: Mabrey, F. Linzee, et al.
Publicado: (2022)

Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease
por: Girard, Thomas J., et al.
Publicado: (2023)

Dexamethasone in patients with diabetes mellitus
por: Greenhill, Claire
Publicado: (2022)

A teenager with CHD and coronavirus disease 2019
por: Olfe, Jakob, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome–Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research
por: Verhoef, Philip A., et al.
Publicado: (2021)

Evaluation of the US Definitions for Coronavirus Disease 2019 Community Risk Levels
por: Mokhtar, Sina, et al.
Publicado: (2022)

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Dexamethasone restrains neutrophils in severe COVID-19
por: Flemming, Alexandra
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019
por: McEneny-King, Alanna C., et al.
Publicado: (2021)

What are the sources of exposure in healthcare personnel with coronavirus disease 2019 infection?
por: Zabarsky, Trina F., et al.
Publicado: (2021)

In Covid-19 Infection, Plasma Extracellular Vesicle Tissue Factor Activity Does Not Correlate with D-Dimer Levels
por: Girard, Thomas J., et al.
Publicado: (2021)

Coronavirus Disease 2019: Associated Multiple Organ Damage
por: Collange, Olivier, et al.
Publicado: (2020)

Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients
por: Newman, Alexander M., et al.
Publicado: (2021)

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
por: Miyazato, Yusuke, et al.
Publicado: (2020)

First Pediatric Case of Coronavirus Disease 2019 in Korea
por: Park, Ji Young, et al.
Publicado: (2020)

Coronavirus disease 2019 in veterans receiving care at veterans health administration facilities
por: Luo, Jessica, et al.
Publicado: (2021)

Preferential use of dexamethasone for fetal lung maturation in severe coronavirus disease 2019
por: Dellapiana, Gabriela, et al.
Publicado: (2020)

Mini-Bronchoalveolar Lavage for Diagnosing Coronavirus Disease 2019–Associated Invasive Pulmonary Aspergillosis
por: Vanbellinghen, Manon C., et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus-2 IgG antibody response to coronavirus disease 2019 vaccination in South Indian health-care professionals with and without coronavirus disease 2019 exposure
por: Jayashri, Ramamoorthy, et al.
Publicado: (2022)

Tropism of Severe Acute Respiratory Syndrome Coronavirus 2 for Barrett’s Esophagus May Increase Susceptibility to Developing Coronavirus Disease 2019
por: Jin, Ramon U., et al.
Publicado: (2021)

Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
por: Sweeney, Daniel A, et al.
Publicado: (2023)

Clinical Outcomes of Acute Pancreatitis in Patients With Coronavirus Disease 2019
por: Dirweesh, Ahmed, et al.
Publicado: (2020)

Unintended Consequences of Coronavirus Disease-2019: Remember General Pediatrics
por: Cherubini, Valentino, et al.
Publicado: (2020)

Outbreak Trends of Coronavirus Disease–2019 in India: A Prediction
por: Tiwari, Sunita, et al.
Publicado: (2020)

Adherence to Lung Protective Ventilation in Patients With Coronavirus Disease 2019
por: Levy, Elizabeth, et al.
Publicado: (2021)

Temporal Changes in the Risk of Superspreading Events of Coronavirus Disease 2019
por: Lim, Jun-Sik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01g0glfons9401rsiba3c91mi4